|
시장보고서
상품코드
2007982
오피오이드 사용 장애(OUD) 시장 : 제품 유형별, 투여 경로별, 제형별, 가용성별, 브랜드별, 연령층별, 유형별, 적응증별, 유통 채널별, 지역별Opioid Use Disorder Market, By Product Type, By Route of Administration, By Dosage Form, By Availability, By Brand, By Age Group, By Type, By Indication, By Distribution Channel, By Geography |
||||||
오피오이드 사용 장애(OUD) 시장은 2026년에 63억 340만 달러로 추정되고 있으며, 2033년까지 98억 6,020만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 9.4%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 63억 340만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년의 예측 기간 CAGR : | 9.40% | 2033년 시장 규모 예측 : | 98억 6,020만 달러 |
세계의 오피오이드 사용 장애(OUD) 시장은 현대의 가장 시급한 공중보건 위기 중 하나를 다루는 매우 중요한 의료 분야입니다. 오피오이드 사용 장애(OUD)는 오피오이드의 유해한 결과에도 불구하고 강박적으로 오피오이드를 사용하는 만성질환으로, 전 세계 수백만 명에게 영향을 미치며 의료 시스템, 가족, 지역사회에 막대한 사회경제적 부담을 안겨주고 있습니다. 이 시장에는 메사돈, 부프레노르핀, 나트렉손과 같은 약물 보조 요법(MAT)과 포괄적인 행동 치료 및 지원 서비스 등 다양한 치료적 개입이 포함됩니다. 오피오이드 과다 복용으로 인해 전 세계에서 수십만 명이 목숨을 잃었고, 중독 발생률이 지속적으로 증가함에 따라 효과적인 치료 솔루션에 대한 수요가 크게 증가하고 있습니다.
이 시장은 증거에 기반한 치료법에 대한 인식의 증가, 의료 접근성을 높이기 위한 정부의 노력, 그리고 전문적인 개입이 필요한 합법적인 의학적 상태로서의 중독에 대한 편견 해소에 힘입어 괄목할 만한 성장세를 보이고 있습니다. 의료 제공자, 제약사, 정책 입안자들은 혁신적인 치료법 개발, 의료 접근성 확대, 피해 감소 전략 실행을 위해 협력하고 있습니다. 디지털 헬스 기술, 원격의료 플랫폼, 개인 맞춤형 치료 접근법의 통합은 이 복잡한 질병에 대처하는 데 있으며, 환자 참여와 치료 최적화를 위한 새로운 기회를 제공함으로써 업계 판도를 더욱 변화시키고 있습니다.
시장 역학
세계의 오피오이드 사용 장애(OUD) 시장은 주로 전 세계 오피오이드 중독 유병률의 급격한 증가에 의해 주도되고 있으며, 선진국과 개발도상국을 막론하고 처방용 오피오이드 남용과 불법 약물 섭취는 전염병 규모에 달했습니다. 메디케이드의 보장 범위 확대, 약물중독치료(MAT)에 대한 사전 승인 요건 폐지 등 근거 기반 치료 접근법을 장려하는 정부의 노력과 정책 개혁이 시장 성장을 크게 촉진하고 있습니다. 중독을 도덕적 결함이 아닌 치료 가능한 의학적 질병으로 인식하는 움직임이 커지면서 낙인이 줄어들고, 더 많은 사람들이 전문적인 도움을 요청하고 있습니다. 원격의료 플랫폼, 모바일 헬스 앱, 원격 모니터링 시스템 등 치료 제공에 있으며, 기술의 발전으로 특히 의료서비스가 부족한 지방에서 접근성과 치료 순응도가 향상되었습니다.
그러나 이 시장은 중독 치료를 둘러싼 뿌리 깊은 편견, 특정 지역의 의료 인프라 부족, 포괄적인 치료 프로그램에 대한 보험 적용 범위의 부족 등 큰 제약에 직면해 있습니다. 복잡한 규제와 특정 약물에 대한 엄격한 처방 요건은 의료진과 환자들에게 장벽이 되고 있습니다. 특히 지방의 경우, 자격을 갖춘 중독 전문의와 치료시설의 부족으로 인해 의료 접근성이 심각하게 제한되고 있습니다. 또한 장기 치료 프로그램의 높은 비용과 각기 다른 의료 시스템 간의 표준화된 치료 프로토콜의 부족도 시장 확대에 걸림돌로 작용하고 있습니다.
그럼에도 불구하고 장기지속형 주사제, 남용방지제 등 새로운 치료법 개발을 통해 큰 성장 기회가 존재합니다. 의료 치료와 행동 의료 서비스를 결합한 통합 케어 모델에 대한 관심이 높아지고 있는 것은 큰 성장 가능성을 보여주고 있습니다. 민관 파트너십과 중독증 연구개발 및 치료 인프라 구축에 대한 자금 지원 확대는 시장 확대를 위한 유망한 경로를 제공하고 있습니다.
본 조사의 주요 특징.
- 세계의 오피오이드 사용 장애(OUD) 시장에 대해 조사 분석했으며, 2025년을 기준연도로 하여 예측 기간(2026-2033년) 시장 규모와 연평균 성장률(CAGR)을 예측한 보고서입니다.
- 이 보고서는 각 부문의 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 보고서는 회사 개요, 제품 포트폴리오, 주요 특징, 재무 성과 및 전략과 같은 매개 변수를 기반으로 세계의 오피오이드 사용 장애(OUD) 시장의 주요 업체를 분석합니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 금융 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 오피오이드 사용 장애(OUD) 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 오피오이드 사용 장애(OUD) 시장 : 제품 유형별, 2021-2033년
제5장 세계의 오피오이드 사용 장애(OUD) 시장 : 투여 경로별, 2021-2033년
제6장 세계의 오피오이드 사용 장애(OUD) 시장 : 제형별, 2021-2033년
제7장 세계의 오피오이드 사용 장애(OUD) 시장 : 가용성별, 2021-2033년
제8장 세계의 오피오이드 사용 장애(OUD) 시장 : 브랜드별, 2021-2033년
제9장 세계의 오피오이드 사용 장애(OUD) 시장 : 연령층별, 2021-2033년
제10장 세계의 오피오이드 사용 장애(OUD) 시장 : 유형별, 2021-2033년
제11장 세계의 오피오이드 사용 장애(OUD) 시장 : 적응증별, 2021-2033년
제12장 세계의 오피오이드 사용 장애(OUD) 시장 : 유통 채널별, 2021-2033년
제13장 세계의 오피오이드 사용 장애(OUD) 시장 : 지역별, 2021-2033년
제14장 경쟁 구도
제15장 애널리스트의 추천
제16장 참고 문헌 및 조사 방법
KSA 26.04.29Opioid Use Disorder Market is estimated to be valued at USD 6,303.4 Mn in 2026 and is expected to reach USD 9,860.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 6,303.4 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.40% | 2033 Value Projection: | USD 9,860.2 Mn |
The global opioid use disorder market represents a critical healthcare segment addressing one of the most pressing public health crises of the modern era. Opioid use disorder is characterized as a chronic medical condition involving the compulsive use of opioids despite harmful consequences, affecting millions of individuals worldwide and imposing substantial socioeconomic burdens on healthcare systems, families, and communities. The market encompasses various therapeutic interventions including medication-assisted treatment (MAT) options such as methadone, buprenorphine, and naltrexone, alongside comprehensive behavioral therapies and support services. With opioid-related overdoses claiming hundreds of thousands of lives globally and addiction rates continuing to escalate, the demand for effective treatment solutions has intensified significantly.
The market has witnessed substantial growth driven by increasing awareness about evidence-based treatments, government initiatives promoting accessible healthcare, and the destigmatization of addiction as a legitimate medical condition requiring professional intervention. Healthcare providers, pharmaceutical companies, and policymakers are collectively working to develop innovative treatment modalities, expand access to care, and implement harm reduction strategies. The integration of digital health technologies, telemedicine platforms, and personalized treatment approaches has further transformed the landscape, offering new opportunities for patient engagement and treatment optimization in addressing this complex disorder.
Market Dynamics
The global opioid use disorder market is primarily driven by the escalating prevalence of opioid addiction worldwide, with prescription opioid misuse and illicit drug consumption reaching epidemic proportions across developed and developing nations. Government initiatives and policy reforms promoting evidence-based treatment approaches, including expanded Medicaid coverage and the elimination of prior authorization requirements for MAT, have significantly boosted market growth. The increasing recognition of addiction as a treatable medical condition rather than a moral failing has reduced stigma and encouraged more individuals to seek professional help. Technological advancements in treatment delivery, including telemedicine platforms, mobile health applications, and remote monitoring systems, have improved accessibility and treatment adherence, particularly in underserved rural areas.
However, the market faces substantial restraints including persistent stigma surrounding addiction treatment, limited healthcare infrastructure in certain regions, and inadequate insurance coverage for comprehensive treatment programs. Regulatory complexities and stringent prescribing requirements for certain medications create barriers for healthcare providers and patients. The shortage of qualified addiction specialists and treatment facilities, particularly in rural areas, significantly limits access to care. Additionally, the high cost of long-term treatment programs and the lack of standardized treatment protocols across different healthcare systems pose challenges to market expansion.
Nevertheless, significant opportunities exist through the development of novel therapeutic interventions, including long-acting injectable formulations and abuse-deterrent medications. The growing emphasis on integrated care models combining medical treatment with behavioral health services presents substantial growth potential. Public-private partnerships and increased funding for addiction research and treatment infrastructure development offer promising avenues for market expansion.
Key Features of the Study
- This report provides in-depth analysis of the global opioid use disorder market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global opioid use disorder market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Indivior, Braeburn, Camurus, Alkermes, Emergent BioSolutions, Orexo, Hikma Pharmaceuticals, Dr Reddy's Laboratories, Alvogen, Sun Pharmaceutical Industries, Amneal Pharmaceuticals, Viatris, Teva Pharmaceuticals, Sandoz, and Kaleo
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global opioid use disorder market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global opioid use disorder market
Market Segmentation
- Product Type Insights (Revenue, USD Mn, 2021 - 2033)
- Buprenorphine
- Oral
- Parenteral
- Others
- Naloxone
- Parenteral
- Others
- Naltrexone
- Oral
- Parenteral
- Combination Drugs
- Methadone
- Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
- Parenteral
- Extended-release Injection for Subcutaneous
- Intramuscular
- Oral
- Sublingual Tablet
- Sublingual Film
- Suspension
- Others
- Dosage Form Insights (Revenue, USD Mn, 2021 - 2033)
- Injections
- Sublingual film
- Sublingual or Buccal
- Tablet
- Suspension
- Others
- Availability Insights (Revenue, USD Mn, 2021 - 2033)
- Prescription
- Over the Counter
- Brand Insights (Revenue, USD Mn, 2021 - 2033)
- Sublocade
- Suboxone
- Brixadi
- Vivitrol
- Zubsolv
- NARCAN
- Others
- Age Group Insights (Revenue, USD Mn, 2021 - 2033)
- Adult
- Children
- Type Insights (Revenue, USD Mn, 2021 - 2033)
- Branded
- Generic
- Indication Insights (Revenue, USD Mn, 2021 - 2033)
- Opioid Addiction
- Pain Management
- Acute
- Chronic
- Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Indivior
- Braeburn
- Camurus
- Alkermes
- Emergent BioSolutions
- Orexo
- Hikma Pharmaceuticals
- Dr Reddy's Laboratories
- Alvogen
- Sun Pharmaceutical Industries
- Amneal Pharmaceuticals
- Viatris
- Teva Pharmaceuticals
- Sandoz
- Kaleo
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Opioid Use Disorder Market, By Product Type
- Global Opioid Use Disorder Market, By Route of Administration
- Global Opioid Use Disorder Market, By Dosage Form
- Global Opioid Use Disorder Market, By Availability
- Global Opioid Use Disorder Market, By Brand
- Global Opioid Use Disorder Market, By Age Group
- Global Opioid Use Disorder Market, By Type
- Global Opioid Use Disorder Market, By Indication
- Global Opioid Use Disorder Market, By Distribution Channel
- Global Opioid Use Disorder Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Opioid Use Disorder Market, By Product Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Buprenorphine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Oral
- Parenteral
- Others
- Naloxone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Parenteral
- Others
- Naltrexone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Oral
- Parenteral
- Combination Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Methadone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Opioid Use Disorder Market, By Route of Administration, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Extended-release Injection for Subcutaneous
- Intramuscular
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Sublingual Tablet
- Sublingual Film
- Suspension
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Opioid Use Disorder Market, By Dosage Form, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Sublingual film
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Sublingual or Buccal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Tablet
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Suspension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Opioid Use Disorder Market, By Availability, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Prescription
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Over the Counter
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Opioid Use Disorder Market, By Brand, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Sublocade
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Suboxone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Brixadi
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Vivitrol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Zubsolv
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- NARCAN
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Opioid Use Disorder Market, By Age Group, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Children
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
10. Global Opioid Use Disorder Market, By Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Branded
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Generic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
11. Global Opioid Use Disorder Market, By Indication, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Opioid Addiction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Acute
- Chronic
12. Global Opioid Use Disorder Market, By Distribution Channel, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
13. Global Opioid Use Disorder Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Channel, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Channel, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
14. Competitive Landscape
- Indivior
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Braeburn
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Camurus
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Alkermes
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Emergent BioSolutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Orexo
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hikma Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dr Reddy's Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Alvogen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amneal Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Viatris
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sandoz
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Kaleo
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
15. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
16. References and Research Methodology
- References
- Research Methodology
- About us
